• U.S. Food & Drug Administration Grants Priority Review of Maribavir americanpharmaceuticalreview
    May 24, 2021
    Takeda Pharmaceutical Company Limited announced that the U.S. Food & Drug Administration (FDA) has accepted a New Drug Application (NDA) for maribavir for the treatment of CMV infection in those that are refractory with or without resistance (R/R) ...
PharmaSources Customer Service